AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2023
Aug 24, 2023
30786_dirs_2023-08-23_6e7595c9-7081-4cab-8ec4-56d02cf0b727.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-08-23
Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | Bio-Rad A Common Stock | S | 300 | $384.69 | Disposed | 2415.7965 | Direct |
Footnotes
F1: Includes 19.319 and 25.114 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 3/31/2023 and 06/30/2023, respectively.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13